<DOC>
	<DOCNO>NCT02925091</DOCNO>
	<brief_summary>Helicobacter pylorus infects ~ 50 % world 's population quarter European population . H. pylori responsible large proportion gastric duodenal ulcer gastritis . Chronic infection H. pylorus risk factor development stomach cancer MALT ( mucosa-associated lymphoid tissue ) Lymphoma . The prospect success antimicrobial eradication therapy drastically reduce significant increase antibiotic resistance Austrian H. pylorus isolates . The currently available data obtain however narrowly defined geographical region clinical routine without information patient selection . We suspect considerable geographical variability resistance pattern clinical bias preferential investigation patient unsuccessful , empirical eradication therapy . The objective propose study therefore Austria-wide collection data H. pylorus resistance prospective clinical study . The data thus collect enable significant improvement current treatment recommendation .</brief_summary>
	<brief_title>Primary Antimicrobial Resistance Patterns Austrian Helicobacter Pylori Clinical Isolates</brief_title>
	<detailed_description />
	<mesh_term>Helicobacter Infections</mesh_term>
	<criteria>Undergoing diagnostic gastroscopy first time live diagnostic gastroscopy reason &gt; 10 year ago Older 18 year age Written inform consent Previous H. pylorus eradication therapy Antimicrobial treatment reason H. pylorus eradication within 3 month prior gastroscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>